MktsMarkets

Caribou Biosciences, Inc.
NASDAQ: CRBUKey statistics
CRBU News
Stories mentioning CRBU from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,397 | 3,941 | 2,198 | 2,667 | 2,353 | 2,077 | 2,024 | 3,464 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 20,611 | 23,815 | 22,401 | 27,692 | 35,531 | 30,464 | 30,421 | 35,480 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 28,677 | 32,394 | 31,598 | 50,245 | 45,266 | 40,952 | 40,262 | 46,965 |
| Operating Income (Loss) | (26,280) | (28,453) | (29,400) | (47,578) | (42,913) | (38,875) | (38,238) | (43,501) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | (9.00) | 0.00 | 0.00 | ||
| Net Income (Loss) | (25,085) | (26,488) | (27,548) | (54,098) | (39,991) | (35,490) | (34,684) | (37,697) |
| Earnings Per Share (Basic) | (0.26) | (0.28) | (0.30) | (0.58) | (0.43) | (0.39) | (0.38) | (0.42) |
| Earnings Per Share (Diluted) | (0.26) | (0.28) | (0.30) | (0.58) | (0.43) | (0.39) | (0.38) | (0.42) |
| Weighted Average Shares Outstanding (Basic) | 95,862 | 93,389 | 93,293 | 93,029 | 92,679 | 90,318 | 90,456 | 90,341 |
| Weighted Average Shares Outstanding (Diluted) | 95,862 | 93,389 | 93,293 | 93,029 | 92,679 | 90,318 | 90,456 | 90,341 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRBU
Caribou Biosciences, Inc. (NASDAQ: CRBU) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRBU. It last traded at $0.3100 (Nov 19, 2026, 9:30 AM ET), down 4.8% on the day. That gives Caribou Biosciences a market capitalisation of $33.5M.
Over the past 52 weeks CRBU has traded between $0.3000 and $2.49.
Revenue for the quarter ended Mar 31, 2026 was $2.4M; a net loss of $25.1M. Revenue was up 1.9% from $2.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.4M | -$25.1M | -1046.5% |
| Dec 31, 2025 | $3.9M | -$26.5M | -672.1% |
| Sep 30, 2025 | $2.2M | -$27.5M | -1253.3% |
| Jun 30, 2025 | $2.7M | -$54.1M | -2028.4% |
From Caribou Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…